Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations
Clinical trial NCT02375022 · UNKNOWN
Trial details
- NCT number
- NCT02375022
- Sponsor
- Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2016-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.